AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Recruitingn/aAges 22 Years - anyAllMedtronic Endovascular
💬

In plain words

What the trial is, and whether it could suit you

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria: 1. Patient treated is age ≥ 22 years at the time of procedure 2. Use of Liberant in accordance with the device labeling within 72 hours of index procedure
💊

What it tests

  • Liberant Thrombectomy System
📍

Where

4 sites
MedStar Health
Washington D.C., United States
Naples Comprehensive Health
Naples, United States
Mount Sinai
New York, United States
Baylor Heart Hospital Of Plano
Plano, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy